Inventor · disambiguated record
Maciej S. Lesniak
Also filed as: LESNIAK MACIEJ · LESNIAK MACIEJ S
6 granted patents·5 pending applications·11 citations·filing 2015–2023
77Inventor score
Top patents by PatentIndex Score
11 records- 0186US10851169B2Conjugates of IL13Rα2 binding agents and use thereof in cancer treatmentUNIV CHICAGO·Filed 2019·Granted Dec 1, 2020·3 cites·27 claims
- 0286US10238699B2Tropic cell based virotherapy for the treatment of cancerHOPE CITY·Filed 2015·Granted Mar 26, 2019·3 cites·17 claims
- 0385US10709745B2Tropic cell based virotherapy for the treatment of cancerHOPE CITY·Filed 2019·Granted Jul 14, 2020·2 cites·12 claims
- 0484US10308719B2IL13Rα2 binding agents and use thereof in cancer treatmentUNIV CHICAGO·Filed 2016·Granted Jun 4, 2019·3 cites·21 claims
- 0573US2024025961A1CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2UNIV CHICAGO·Filed 2023·Application pending·0 cites
- 0669US11827712B2IL13Rα2 binding agents and use thereofUNIV CHICAGO·Filed 2020·Granted Nov 28, 2023·0 cites·19 claims
- 0768US11673935B2Car T-cells recognizing cancer-specific IL 13Ra2UNIV CHICAGO·Filed 2019·Granted Jun 13, 2023·0 cites·5 claims
- 0864US2021060101A1Tropic cell based virotherapy for the treatment of cancerHOPE CITY·Filed 2020·Application pending·0 cites
- 0956US2024209313A1B-cell based immunotherapy for the treatment of glioblastoma and other cancersUNIV NORTHWESTERN·Filed 2021·Application pending·0 cites
- 1052US2018170992A1CAR T CELLS RECOGNIZING CANCER-SPECIFIC IL 13Ra2UNIV CHICAGO·Filed 2016·Application pending·0 cites
- 1152US2021128725A1Cytotoxic lipid particles targeted to tumor-associated myeloid cells (tamcs) and synergized with radiation therapy for treating glioblastomaUNIV NORTHWESTERN·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maciej S. Lesniak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →